2 leading COVID-19 treatments aren't working against omicron variant

0 Views
Published
Monoclonal antibody treatments that doctors used to prevent severe illness and hospitalizations may not be an option in the fight against omicron. Health leaders said COVID-19 antibody treatments made by Regeneron and Eli Lilly were found ineffective against omicron.

“We’ve given thousands of doses during the pandemic,” Dr. David Priest with Novant Health said. “[These treatments] are not going to be effective against the omicron variant, and these are the IV infusion treatments that healthcare systems have been using.”

This comes as COVID-19 cases in the North Carolina area are record-breaking with omicron continuing to spread through the state.

“We are seeing transmission at levels we have not seen before,” Mecklenburg County Health Director Dr. Raynard Washington said.

READ MORE: https://www.wcnc.com/article/news/health/coronavirus/monoclonal-antibody-treatment-covid-19-omicron/275-1f79a0a9-2ea8-4492-8aa4-a837b3b04879
Category
Health
Be the first to comment